3Eschbach JW.Correction of the anemia of end-stage renal disease with recombinant human erythropoietin:results of a combinant phase Ⅰand Ⅱclinical trial.New Engl J Med,1987;316:73.
4Casati S.et al.Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having hemodialysis.Br Med J,1987;295:1017.
5US rHu Epo Predialysis Study Group.Double-blind.placebocontrolled study of the therapeutic use of rHu Epo for anemia associated with chromic renal failure in predialysis patients.Am J Kidney Dis,1997;18:50.
6Brown CD.et al.Treatment of azotemic,Nonoliguric.anemic patients with human recombinant erythropoietin raises whole viscosity proportioal to hematocrit.Nephron,1991;59:394.
7Lui SF.et al.Once weekly versus twice weekly subcutaneous administration of recombinant human eryhropoietin in patients on continuous ambulatory peritoneal dialysis.Clin Nephrol,1991;36:246.
